Payer

Payers are expecting big gains in Medicare Advantage enrollment in 2023 as the program now represents more than half of Medicare beneficiaries. 

From signing a definitive agreement to sell an artificial intelligence platform, to shareholders rejecting a pair of proposals zeroing in on executive pay, here are eight updates about Centene that Becker's reported since April 26:

Independence Blue Cross and Philadelphia-based Penn Medicine are piloting a program that allows qualifying physicians to skip prior authorization approvals needed for ultrasounds, CT scans and PET scans. 

Aetna, UnitedHealthcare and two other insurance companies will pay a combined $4.6 million to New York state to settle allegations the companies charged unapproved rates for student insurance. 

Prominent insurtech companies — Bright Health Group, Clover Health and Oscar Health — posted a combined $281.7 million in losses in the first quarter of 2023. 

HHS' Office of Inspector General has found several Medicare Advantage plans received overpayments in recent months. 

Humana had the largest Medicare Advantage membership growth in the first quarter of 2023, according to the company's earnings report. 

Clover Health boosted its insurance segment revenue and slightly improved on its losses in the first three months of 2023. 

Nearly 90 prior authorization reform bills have been introduced in 30 state legislatures this year, according to the American Medical Association. 

Preliminary results show Centene shareholders rejected a pair of proposals that took aim at executive pay, the St. Louis Business Journal reported May 10.